Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Effectiveness of Virtually Simulated Intervention for Patients Having Stuttering

21 de septiembre de 2026 actualizado por: Riphah International University

This randomized controlled trial aims to evaluate the effectiveness of a culturally appropriate virtual reality (VR)-based speech restructuring intervention for individuals with stuttering in Pakistan. The intervention consists of five VR scenarios representing common real-life communication situations, incorporating graded difficulty levels, speech restructuring techniques, relaxation exercises, interactive avatars, and realistic audiovisual elements.

Eligible participants with stuttering will be randomly allocated to an experimental group receiving the VR-based speech restructuring intervention or a control group. Participants in the experimental group will receive 16 therapy sessions using the developed VR scenarios. Assessments will be conducted at baseline, during the intervention, and after completion of the intervention to evaluate changes in stuttering severity, speech fluency, communication attitudes, associated motor behaviors, physiological factors, and sense of presence within the virtual environment.

The study will determine whether the VR-based intervention is effective in improving speech fluency and reducing the severity and associated features of stuttering compared with the control condition. The findings will provide evidence regarding the effectiveness of VR-based speech restructuring as a culturally appropriate intervention for individuals with stuttering.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Descripción detallada

This study is a randomized controlled trial designed to evaluate the effectiveness of a culturally adapted virtual reality (VR)-based speech restructuring intervention for individuals with stuttering in Pakistan. The intervention has been developed to simulate everyday communication situations within a controlled, immersive, and progressively challenging virtual environment. The overall objective of the trial is to determine whether VR-based speech restructuring can improve speech fluency and reduce stuttering severity and associated behavioral, physiological, and communication-related difficulties.

The VR intervention consists of five culturally appropriate communication scenarios representing commonly encountered real-life speaking situations in the Pakistani context: lecture hall, grocery store, restaurant, telephone conversation, and job interview. The scenarios incorporate graded levels of communication difficulty and are designed to provide opportunities for participants to practice speech restructuring techniques in progressively challenging situations. The intervention includes realistic environmental sounds, interactive avatars of different ages and genders, adjustable audience size and positioning, emotional expressions, varying question types, distractors, time-limited speaking tasks, relaxation exercises, and opportunities for repeated practice of speech restructuring techniques.

The intervention will be delivered using the Oculus Quest 2 head-mounted display. A neutral adaptation environment will be used to familiarize participants with the VR equipment and virtual environment before exposure to the therapeutic scenarios. Standard operating procedures (SOPs) will be followed to ensure standardized equipment setup, participant orientation, intervention delivery, and safety throughout the study. The intervention protocol and VR scenarios were developed and refined through a structured development process, including literature review, observation of real-life communication situations, brainstorming and ideation, storyboard development, live-action role plays, conversion into immersive virtual environments, and expert review. Content validity of the developed scenarios was established through evaluation by six experts with relevant professional experience using the Content Validity Index (CVI).

Eligible participants with stuttering will be recruited according to predefined inclusion and exclusion criteria. Participants will be randomly allocated to the experimental group or control group. The experimental group will receive the VR-based speech restructuring intervention consisting of 16 therapy sessions conducted three times per week, with each session lasting approximately 25 minutes. The intervention will begin with orientation to the VR system and training in the speech restructuring techniques. Participants will then practice the techniques within the five virtual communication scenarios, with the level of difficulty progressively increased according to the intervention protocol. Later sessions will focus on integrating skills across different communication situations and facilitating the transfer of learned speech restructuring strategies to real-life communication environments.

Participants in the control group will receive the control condition specified in the study protocol. Both groups will undergo outcome assessment at predefined time points. Baseline assessment will be conducted before commencement of the intervention, followed by an interim assessment during the intervention and a post-intervention assessment after completion of the 16 sessions. The primary outcome will be the severity of stuttering. Secondary outcomes will assess speech fluency, communication attitudes and emotions, associated motor behaviors, physiological factors associated with stuttering, and participants' sense of presence within the virtual environment, where applicable.

Speech fluency and stuttering-related outcomes will be assessed using standardized and structured assessment procedures. Outcome measures will include real-time analysis of speech fluency and dysfluency index, assessment of physiological factors associated with stuttering, the Modified S Scale for communication attitudes and emotions, assessment of associated motor behaviors, and the Presence Questionnaire for evaluating participants' experience within the virtual environment.

Data will be analyzed using SPSS. Descriptive statistics will be used to summarize participant characteristics and outcome measures. Appropriate inferential statistical tests will be used to compare changes in outcome measures between the experimental and control groups and across the predefined assessment time points. Statistical significance will be determined according to the prespecified analysis plan. The results of this randomized controlled trial will provide evidence regarding the effectiveness of a culturally adapted VR-based speech restructuring intervention for individuals with stuttering and its potential application as an adjunct or alternative approach to conventional stuttering intervention.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

44

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Humaira Shamim Dr. Humaira Shamim Kiyani, PhD Rehabilitation Sciences
  • Número de teléfono: +923005471389
  • Correo electrónico: humaira.shamim@riphah.edu.pk

Ubicaciones de estudio

      • Islamabad, Pakistán, 4600
        • National Institute of Rehabilitation Medicine
        • Contacto:
        • Contacto:
        • Investigador principal:
          • Tehreem Ijaz, PhD Scholar

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

13 años a 35 años (Niño, Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Participants having stuttering of any level will be included.
  • Participants having any primary behaviors like blocking, prolongations, Repetitions will be included.
  • Participants exhibiting any facial grimaces, body movements or muscular tensions will be included.
  • Age range 13-35 years (35)
  • Both Genders
  • Participants having stuttering severity from mild to severe
  • Bilingual population having at-least matriculation qualification

Exclusion Criteria:

  • Participants who have other communication problems with stuttering
  • Participants who have any associated medical condition like stroke, head trauma, or any other brain injury will also be excluded
  • Participants who had psychological problems, like depression and anxiety will be excluded from study.
  • Participants who had any intellectual or cognitive disability will be excluded from study.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Virtually Simulated Intervention

Participants receive the virtually simulated intervention developed for the management of stuttering. The study will evaluate the effectiveness of this intervention on the targeted population.

A standardized, virtually simulated intervention comprising 2D video-based communication scenarios delivered using a Meta Quest 2 virtual reality headset. Participants viewed and controlled the playback of the simulated scenarios during therapy sessions according to the study protocol. Participants will receive intervention 3 days/week for 25 minutes. A total of 16 sessions will be conducted.

Comparador activo: Fluency Shaping Techniques

Participants will receive the intervention as per described intervention protocol.

Participants in the control group will receive traditional speech intervention for stuttering without the use of virtual reality. The intervention will involve therapist-guided practice of speech restructuring techniques in clinics by using scenario-based solutions. Participants will receive intervention sessions according to the same treatment schedule and duration as the experimental group. The intervention will focus on improving speech fluency and reducing the severity of stuttering through structured practice and application of speech restructuring techniques in everyday communication situations.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Severity of Stuttering
Periodo de tiempo: Baseline and approximately 6 weeks (post-test, immediately after completion of the 16-session intervention)

Change from baseline in percentage of syllables stuttered will be assessed to determine changes in speech fluency following the intervention. Speech samples consisting of 200 syllables will be analyzed. The percentage of syllables stuttered will be calculated by dividing the number of syllables containing stuttering events by the total number of syllables produced and multiplying by 100. A decrease in the percentage of syllables stuttered indicates an improvement in speech fluency.

Baseline and approximately 6 weeks (post-test, immediately after completion of the 16-session intervention)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Overall Assessment of Speaker's Experience of Stuttering
Periodo de tiempo: Baseline and approximately 6 weeks

Change from baseline in the overall impact of stuttering will be assessed using the Overall Assessment of the Speaker's Experience of Stuttering (OASES). The OASES assesses the speaker's experience of stuttering across multiple domains, including general information about stuttering, reactions to stuttering, communication in daily situations, and quality of life. The instrument provides an overall impact score, with higher scores indicating a greater negative impact of stuttering on the individual's life. Changes in the overall impact score from baseline to post-test will be evaluated to determine the effectiveness of the intervention.

Baseline and approximately 6 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Tehreem Ijaz, PhD Scholar, Riphah International University

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

25 de octubre de 2026

Finalización primaria (Estimado)

15 de diciembre de 2026

Finalización del estudio (Estimado)

15 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

21 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

21 de septiembre de 2026

Publicado por primera vez (Actual)

28 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

28 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

21 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir